To shore up the system, states could be required to improve experience rating and maintain adequate trust fund balances.
"This will be the first major effort to deal with the underlying causes — that is, lack of adequate trust between our two countries," Mr. Singh told reporters, noting that any progress was contingent on Pakistan's stopping attacks against India by terrorist groups within its borders.
Therefore, hospitals must ensure that the nurses have adequate trust in the hospital.
We should not expect a single leader or intervention to deliver an abrupt end to the HIV/AIDS pandemic, yet the tide can be turned with principled pragmatism, adequate resources, trust in communities, and science as our guide.
In addition, Toseland et al. [ 27] suggest that health care workers can help reduce some of the barriers to accepting assistance by developing trust, adequate collaborative planning, providing information and advice, listening, clarifying for caregivers the nature of respite, and providing emotional support.
Reading the story, Rifat sighed and embarked on his favorite theme — such things never happened in the days of Abdel Nasser, when subsidies were adequate and people trusted the government, and the streets emptied on the first Thursday of every month, because all of Cairo was listening to Om Kalthoum.
When asked what makes the best companies the best, employees noted that the top firms operate as meritocracies, possess adequate resources, have trusted brands, and are responsive to stakeholders.
Assurance that these reasons are sufficient to lead somebody to accept a lower level of control over their data than they would ideally prefer depends in part upon a trust that adequate alternative safeguards exist to address their concerns and to protect their interests.
Their verdict on whether that plan is adequate — and whether they trust the Greek government to implement it — will determine, to a great extent, whether Greece will continue to use the euro.
Establishing trust and adequate knowledge exchange between CCG and provider entities remained an on-going challenge.
Clinical trialists working in phase II and III studies have to trust that adequate time and attention have been paid in earlier phases of drug development to the identification of the appropriate drug dose.
